FDA Approved: MARGENZA — Original Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA approved MARGENZA (margetuximab-cmkb) from TerSera Therapeutics as an original application for adults with metastatic HER2-positive breast cancer after two …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MARGENZA (MARGETUXIMAB-CMKB)

Snippet

ORIG AP for MARGENZA (MARGETUXIMAB-CMKB)